Andre Martin Kasko, D.O. Obstetrics & Gynecology - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 57445 29 Palms Hwy, Suite 301, Yucca Valley, CA 92284 Phone: 760-365-2800 Fax: 760-365-1406 |
News Archive
In a proof-of-principle study, a team of physicians and bioinformatics experts at Johns Hopkins reports they were able to diagnose or rule out suspected brain infections using so called next-generation genetic sequencing of brain tissue samples.
A drug already approved for treating other diseases may be useful as a treatment for cerebral malaria, according to researchers at Harvard T. H. Chan School of Public Health. They discovered a novel link between food intake during the early stages of infection and the outcome of the disease, identifying two molecular pathways that could serve as new targets for treatment.
The future of medicine is now dawning upon us.Nanomedicines demonstrate the capability to enhance drug properties by offering protection from degradation, enabling controlled release and biodistribution and increasing bioavailability.
ISTA Pharmaceuticals, Inc., today announced preliminary results from two recently completed studies on its investigational ophthalmic product, T-Pred (prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension). The Company is developing T-Pred as a treatment for inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial ocular infection exists, or there is a risk of bacterial infection.
The Translational Genomics Research Institute (TGen) provides Arizona with an annual total economic impact of $77.4 million, according to the results of an independent analysis released today.
› Verified 8 days ago